The association between inflammatory biomarkers and metabolically healthy obesity depends of the definition used

European Journal of Clinical Nutrition

Volumn 66, Issue 4, 2012, Pages 426-435

  Marques Vidal, P ^a   Velho, S ^b   Waterworth, D ^c   Waeber, G ^d   Von Kanel R ^e   Vollenweider, P ^d  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^c GLAXOSMITHKLINE   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

body mass index; C reactive protein; interleukin 1beta; ; interleukin 6; obesity; tumour necrosis factor

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT DISTRIBUTION; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METABOLIC DISORDER; METABOLICALLY HEALTHY OBESITY; OBESITY; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LINEAR MODELS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREVALENCE; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859447792     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2011.170     Document Type: Article

References (38)

1. Abbatecola AM, Ferrucci L, Grella R, Bandinelli S, Bonafè M, Barbieri M et al. (2004). Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J Am Geriatr Soc 52, 399-404. (Pubitemid 38339521)
2. Aguilar-Salinas CA, Garćia EG, Robles L, Riaño D, Ruiz-Gomez DG, Garcia-Ulloa AC et al. (2008). High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93, 4075-4079.
3. Basu A, Devaraj S, Jialal I (2006). Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 26, 995-1001. (Pubitemid 43732103)
4. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K et al. (2003). Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol 92, 522-528. (Pubitemid 37013402)
5. Coppack SW (2001). Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 60, 349-356. (Pubitemid 32772450)
6. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB et al. (2008). Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 5, e78.
7. Deurenberg P (2001). Universal cut-off BMI points for obesity are not appropriate. Br J Nutr 85, 135-136. (Pubitemid 32236797)
8. Di Renzo L, Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Calabrese V et al. (2008). Body composition and-174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharm Des 14, 2699-2706.
9. Dupont NC, Wang K, Wadhwa PD, Culhane JF, Nelson EL (2005). Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. J Reprod Immunol 66, 175-191. (Pubitemid 41073746)
10. Escobar-Morreale HF, Villuendas G, Botella-Carretero JI, Sancho J, San Millan JL (2003). Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women. Diabetologia 46, 625-633. (Pubitemid 36808182)
11. Firmann M, Mayor V, Marques-Vidal P, Bochud M, Pecoud A, Hayoz D et al. (2008). The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8, 6.
12. Fischer CP, Berntsen A, Perstrup LB, Eskildsen P, Pedersen BK (2007). Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 17, 580-587.
13. Flower L, Ahuja RH, Humphries SE, Mohamed-Ali V (2000). Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 12, 1712-1716.
14. Frohlich M, Sund M, Lowel H, Imhof A, Hoffmeister A, Koenig W (2003). Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J 24, 1365-1372. (Pubitemid 36917708)
15. Galland L (2010). Diet and inflammation. Nutr Clin Pract 25, 634-640.
16. Ghosh S, Meister D, Cowen S, Hannan WJ, Ferguson A (1997). Body composition at the bedside. Eur J Gastroenterol Hepatol 9, 783-788. (Pubitemid 27332028)
17. Karelis AD, Brochu M, Rabasa-Lhoret R (2004). Can we identify metabolically healthy but obese individuals (MHO)? Diab Metab 30, 569-572. (Pubitemid 40070359)
18. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D et al. (2005). The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 90, 4145-4150. (Pubitemid 41058189)
19. Koster A, Stenholm S, Alley DE, Kim LJ, Simonsick EM, Kanaya AM et al. (2010). Body fat distribution and inflammation among obese older adults with and without metabolic syndrome. Obesity (Silver Spring) 18, 2354-2356.
20. Lynch LA, O'Connell JM, Kwasnik AK, Cawood TJ, O'Farrelly C, O'Shea DB (2009). Are natural killer cells protecting the metabolically healthy obese patient? Obesity (Silver Spring) 17, 601-605.
21. Martin A, O'Sullivan AJ, Brown MA (2001). Body composition and energy metabolism in normotensive and hypertensive pregnancy. BJOG 108, 1263-1271. (Pubitemid 34076738)
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. (Pubitemid 15018832)
23. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM et al. (2006). Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 91, 2906-2912. (Pubitemid 44271734)
24. Messier V, Karelis AD, Prud'homme D, Primeau V, Brochu M, Rabasa-Lhoret R (2010). Identifying metabolically healthy but obese individuals in sedentary postmenopausal women. Obesity (Silver Spring) 18, 911-917.
25. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS et al. (1997). Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82, 4196-4200. (Pubitemid 27525539)
26. Park HS, Park JY, Yu R (2005). Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diab Res Clin Pract 69, 29-35. (Pubitemid 40813409)
27. Payette C, Blackburn P, Lamarche B, Tremblay A, Bergeron J, Lemieux I et al. (2009). Sex differences in postprandial plasma tumor necrosis factor-alpha, interleukin-6, and C-reactive protein concentrations. Metabolism 58, 1593-1601.
28. Qi L, Zhang C, van Dam RM, Hu FB (2007). Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26,944 individuals. J Clin Endocrinol Metab 92, 3618-3625. (Pubitemid 47435347)
29. Shin MJ, Hyun YJ, Kim OY, Kim JY, Jang Y, Lee JH (2006). Weight loss effect on inflammation and LDL oxidation in metabo-lically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 30, 1529-1534. (Pubitemid 44470202)
30. Simpson JA, Lobo DN, Anderson JA, Macdonald IA, Perkins AC, Neal KR et al. (2001). Body water compartment measurements: a comparison of bioelectrical impedance analysis with tritium and sodium bromide dilution techniques. Clin Nutr 20, 339-343. (Pubitemid 32785475)
31. Skeppholm M, Wallén NH, Blombäck M, Kallner A (2008). Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations? Clin Chem Lab Med 46, 1175-1179.
32. Steiner MC, Barton RL, Singh SJ, Morgan MD (2002). Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 19, 626-631. (Pubitemid 34285158)
33. Stowe RP, Peek MK, Cutchin MP, Goodwin JS (2010). Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci 65, 429-433.
34. Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis JC, Raptis SA et al. (1999). Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 48, 1332-1335. (Pubitemid 29496085)
35. Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P (2010). Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 64, 1043-1051.
36. Vignali DA (2000). Multiplexed particle-based flow cytometric assays. J Immunol Methods 243, 243-255.
37. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J et al. (2008). The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 168, 1617-1624.
38. Wolf HK, Kuulasmaa K, Tolonen H, Ruokokoski E (1998). Participation Rates, Quality of Sampling Frames and Sampling Fractions in the MONICA Surveys. WHO MONICA: Helsinki, Finland.